DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 6Dr. Reddy's Laboratories
02 16Accord healthcare
03 2Aspiro Pharma
04 1Aurobindo Pharma Limited
05 5Baxter Healthcare Corporation
06 1Bayer AG
07 2Be Pharma B.V.
08 1Biocon
09 4Biological E
10 4CUBIST PHARMS INC
11 2Cipla
12 1Clinigen Group
13 1DR REDDY'S LABORATORIES LTD
14 2Deva Holding AS
15 1Dr Reddy's Laboratories (Pty) Ltd
16 1Fosun Pharmaceutical
17 2Fresenius Kabi USA
18 3Hainan Poly Pharm
19 1Hameln Pharma GmbH
20 1Hangzhou Zhongmei Huadong Pharmaceutical
21 2Health Biotech
22 7Hikma Pharmaceuticals
23 4Hospira, Inc.
24 2Jiangsu Hengrui Medicine
25 1Kahma Group
26 1Kaliberr Labs
27 2LABORATORIOS NORMON SA
28 2Labatec Pharm
29 2Lorien Laboratories Sl
30 2MIP Pharma
31 2MSD Pharmaceuticals
32 1Macleods Pharmaceuticals Limited
33 2Maia Pharmaceuticals
34 2Meitheal Pharmaceuticals
35 8Merck & Co
36 2Noridem Enterprises Ltd
37 2Olon S.p.A
38 2Pfizer Inc
39 1Pharma Dynamics
40 1Qilu Pharmaceutical
41 2Reig Jofre
42 2Sagent Pharmaceuticals
43 1Sandoz B2B
44 2Tarbis Farma Sl
45 1Teva Pharmaceutical Industries
46 2Tillomed Laboratories Ltd
47 2Viatris
48 5Xellia Pharmaceuticals ApS
49 2Zentiva
50 1Zhejiang Hisun Pharmaceutical
01 2 Powder for Solution (Lyophilized Powder)
02 1Daptomycin 350Mg 1 Unit Parenteral Use
03 1Daptomycin 500Mg 10Ml 1 Units Parenteral Use
04 5INF
05 1INJ
06 6Injection
07 21Injection/Infusion Solution
08 2Lyophilizate
09 2Lyophilized Injection
10 1POI
11 4POWDER FOR SOLUTION
12 38POWDER;INTRAVENOUS
13 23Powder For Injection And Infusion Solution
14 5Powder For Solution For Injection And Infusion
15 1Powder for injection/infusion fluid, resolution
16 4SOLUTION;INTRAVENOUS
17 4Solution For Injection
18 4Vial
01 6Allowed
02 19Approved
03 24Authorized
04 1Available Dossier- US-EU-RoW
05 2Cancelled
06 8DISCN
07 10Generic
08 2Lead Market Dossiers- Filed
09 1Originator
10 4Prescription
11 33RX
12 2Suspensed
13 13Blank
01 1CUBACT
02 2CUBICIN
03 2CUBICIN RF
04 10Cubicin
05 1Cusyn
06 1DABUCOR 500
07 34DAPTOMYCIN
08 3DAPTOMYCIN FOR INJECTION
09 4DAPTOMYCIN IN 0.9% SODIUM CHLORIDE
10 1DAPZURA RT
11 1Dapicub
12 2Daptomicina Accord
13 2Daptomicina Accordpharma
14 1Daptomicina Baxter
15 2Daptomicina Cipla
16 1Daptomicina Fosun Pharma
17 2Daptomicina Hikma
18 2Daptomicina Lorien
19 2Daptomicina Normon
20 2Daptomicina Tarbis
21 2Daptomicina Tillomed
22 2Daptomicina Xellia
23 2Daptomycin Accord
24 4Daptomycin Accord Healthcare
25 2Daptomycin Accordpharma
26 2Daptomycin Be Pharma
27 1Daptomycin Equity
28 1Daptomycin Hameln
29 2Daptomycin Hikma
30 2Daptomycin Hospira
31 2Daptomycin Labatec
32 2Daptomycin Mip
33 2Daptomycin Noridem
34 2Daptomycin Reddy
35 2Daptomycin Sala
36 2Daptomycin Zentiva
37 1Drymred 500
38 16Blank
01 4Canada
02 3China
03 2Denmark
04 7India
05 4Italy
06 1Norway
07 7South Africa
08 28Spain
09 19Sweden
10 6Switzerland
11 2Turkey
12 42USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : DAPTOMYCIN
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : 500MG/VIAL
Packaging :
Approval Date : 2019-05-01
Application Number : 208375
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : DAPTOMYCIN
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : 350MG/VIAL
Packaging :
Approval Date : 2020-08-31
Application Number : 211403
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 350MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 500MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Daptomycin Reddy
Dosage Form : Injection/Infusion Solution
Dosage Strength : 350mg
Packaging :
Approval Date : 12/09/2017
Application Number : 20160601000022
Regulatory Info : Approved
Registration Country : Sweden
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Daptomycin Reddy
Dosage Form : Injection/Infusion Solution
Dosage Strength : 500mg
Packaging :
Approval Date : 12/09/2017
Application Number : 20160601000039
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : DISCN
Registration Country : USA
Brand Name : CUBICIN
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : 250MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2003-09-12
Application Number : 21572
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : CUBICIN
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2003-09-12
Application Number : 21572
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : CUBICIN RF
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2016-07-06
Application Number : 21572
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DAPTOMYCIN
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : 500MG/VIAL
Packaging :
Approval Date : 2018-04-11
Application Number : 206077
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DAPTOMYCIN
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : 350MG/VIAL
Packaging :
Approval Date : 2017-10-20
Application Number : 209949
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DAPTOMYCIN
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : 500MG/VIAL
Packaging :
Approval Date : 2014-09-12
Application Number : 202857
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : DAPTOMYCIN
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : 350MG/VIAL
Packaging :
Approval Date :
Application Number : 203797
Regulatory Info :
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DAPTOMYCIN
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : 350MG/VIAL
Packaging :
Approval Date : 2021-06-21
Application Number : 210282
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DAPTOMYCIN
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : 500MG/VIAL
Packaging :
Approval Date : 2021-06-21
Application Number : 210282
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DAPTOMYCIN
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : 500MG/VIAL
Packaging :
Approval Date : 2019-11-15
Application Number : 207104
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DAPTOMYCIN
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : 350MG/VIAL
Packaging :
Approval Date : 2017-09-12
Application Number : 208385
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DAPTOMYCIN
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : 500MG/VIAL
Packaging :
Approval Date : 2016-03-25
Application Number : 91039
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DAPTOMYCIN
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : 500MG/VIAL
Packaging :
Approval Date : 2018-06-05
Application Number : 205037
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DAPTOMYCIN
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : 500MG/VIAL
Packaging :
Approval Date : 2016-06-15
Application Number : 206005
Regulatory Info : RX
Registration Country : USA
